The present invention relates generally to the treatment of end stage renal disease. More specifically, the present invention relates to methods and apparatus for monitoring the performance of peritoneal dialysis.
Using dialysis to support a patient whose renal function has decreased to the point where the kidneys no longer sufficiently function is known. Two principal dialysis methods are utilized: hemodialysis; and peritoneal dialysis.
In hemodialysis, the patient's blood is passed through an artificial kidney dialysis machine. A membrane in the machine acts as an artificial kidney for cleansing the blood. Because it is an extracorporeal treatment that requires special machinery, certain inherent disadvantages exist with hemodialysis.
To overcome the disadvantages associated with hemodialysis; peritoneal dialysis was developed. Peritoneal dialysis utilizes the patient's own peritoneum as a semi-permeable membrane. The, peritoneum is a membranous lining of the abdominal body cavity. Due to good perfusion, the peritoneum is capable of acting as a natural semi-permeable membrane.
Peritoneal dialysis periodically infuses sterile aqueous solution into the peritoneal cavity. This solution is called peritoneal dialysis solution, or dialysate. Diffusion and osmosis exchanges take place between the solution and the blood stream across the natural body membranes. These exchanges remove the waste products that the kidneys normally excrete. The waste products typically consist of solutes like urea and creatinine. The kidneys also maintain the levels of other substances such as sodium and water which need to be regulated by dialysis. The diffusion of water and solutes across the peritoneal membrane during dialysis is called ultrafiltration.
In continuous ambulatory peritoneal dialysis, a dialysis solution is introduced into the peritoneal cavity utilizing a catheter. An exchange of solutes between the dialysate and the blood is achieved by diffusion. Further removal is achieved by providing a suitable osmotic gradient from the blood to the dialysate to permit water outflow from the blood. This allows a proper acid-base, electrolyte and fluid balance to be achieved in the body. The dialysis solution is simply drained from the body cavity through the catheter.
Peritoneal dialysis raises a number of concerns including: the danger of peritonitis; a lower efficiency and therefore increased duration of dialysis hours compared to hemodialysis; and costs incurred when automated equipment is utilized.
A number of variations on peritoneal dialysis have been explored. One such variation is automated peritoneal dialysis (“APD”). APD uses a machine, called a cycler, to automatically infuse, dwell, and drain peritoneal dialysis solution to and from the patient's peritoneal cavity. APD is particularly attractive to a peritoneal dialysis patient, because it can be performed at night while the patient is asleep. This frees the patient from the day-to-day demands of continuous ambulatory peritoneal dialysis during his/her waking and working hours.
The APD sequence typically lasts for several hours. It often begins with an initial drain cycle to empty the peritoneal cavity of spent dialysate. The APD sequence then proceeds through a succession of fill, dwell, and drain phases that follow one after the other. Each fill/dwell/drain sequence is called a cycle. APD can be and is practiced in a number of different ways.
Current APD systems do not monitor the patient intraperitoneal pressure during a therapy session. Current systems simply limit the external pressure (or suction) that a pump can apply to the line or lumen that is attached to the patient catheter. If the patient is located below the system, sometimes referred to as a cycler, a gravity head will add to the positive fill pressure that the cycler can apply to the patient catheter. Conversely, if the patient is located above the cycler, the gravity head will decrease from the positive fill pressure that the cycler can apply to the patient catheter.
The monitoring of intraperitoneal pressure would be useful because cyclers will sometimes not fully drain a patient between cycles. Specifically, currently-available cyclers are unable to determine whether a patient absorbed some fluid or whether some fluid is simply not able to be drained out because of the position of the patient or the catheter.
As a result, some currently-available systems utilize a minimum drain threshold to determine the amount of fluid that should be delivered to the patient during the next fill. For example, if 85% of the fill volume has been drained when the cycler determines that the patient is “empty”, the next fill volume will be 100%. If only 80% were drained, the next fill volume would be limited to 95%.
A negative ultrafiltrate (uF) alarm will sound when the patient has retained more than a predetermined percentage of the fill volume. The predetermined percentage can typically be either 50% or 100% of the fill volume. However, the patient can override this alarm if he/she does not feel overfull. The number of times the patients can override the uF alarm during a single therapy may be limited by the software of the cycler. However, the uF alarm typically does not consider the actual ultrafiltrate that may also accumulate in the peritoneal cavity along with the dialysate.
Currently-available cyclers fill the patient to a specific, preprogrammed volume during each cycle. The doctor prescribes this fill volume based upon the patient's size, weight and other factors. However, because currently-available cyclers cannot monitor intraperitoneal pressure, the doctor cannot take this factor into account when formulating the prescription. It is also known that intraperitoneal pressure (IPP) has an effect on ultrafiltration (UF).
Referring to
Turning to
Turning to
The drain and fill rates of the cyclers 10a-10c illustrated in
Accordingly, there is a need for an improved cycler that measures patient intraperitoneal pressure during a therapy session, including both during the drain and the fill as well as the dwell. Further, there is a need for an improved cycler that measures intraperitoneal pressure and which would use that data to more completely drain a patient between cycles. Further, there is a need for an improved cycler which would accurately measure intraperitoneal pressure to avoid overfilling a patient. Finally, there is a need for an improved cycler which would monitor intraperitoneal pressure during both the fill and drain cycles to optimize the speed at which the patient is filled and drained and to therefore increase the dwell portion of a therapy session.
The present invention satisfies the aforenoted needs by providing a system for providing peritoneal dialysis to a patient which comprises a dialysate container connected to the patient with a first pressure sensor connected in-line therebetween, and a drain container connected to the patient with a second pressure sensor connected in-line therebetween.
In an embodiment, the system further comprises a first pump disposed in-line between the dialysate container and the first pressure sensor.
In an embodiment, the dialysate flows from the dialysate container into the patient under a hydrostatic head.
In an embodiment, a second pump is disposed in-line between the drain container and the second pressure sensor.
In an embodiment, the dialysate flows from the patient to the drain container under a hydrostatic head.
In an embodiment, the second pressure sensor measures an intraperitoneal pressure of the patient while dialysate flows from the dialysate container to the patient.
In an embodiment, the first pressure sensor measures an intraperitoneal pressure of the patient while dialysate flows from the patient to the drain container.
In an embodiment, the system further comprises a first lumen connecting the dialysate container to the first sensor and the first sensor to a catheter, and a second lumen connecting the drain container to the second sensor and the second sensor to the catheter, the catheter being connected to the patient, a flow of dialysate from the patient to the drain container evacuating dialysate from the first lumen and causing said dialysate from the first lumen to flow through the second lumen and to the drain container.
In an embodiment, the catheter is a dual lumen catheter.
In an embodiment, the first and second sensors are redundant in-line pressure/vacuum sensors.
In an embodiment, the present invention provides a method for dialyzing a patient comprising the steps of: placing a catheter in a peritoneum of the patient; providing at least one dialysate container; connecting the dialysate container to the catheter with a first lumen that includes a first pressure sensor disposed in-line and between the catheter and the dialysate container; providing at least one drain container; connecting the drain container to the catheter with a second lumen that includes a second pressure sensor disposed in-line and between the catheter and the drain container; transferring dialysate from the dialysate container to the peritoneum of the patient and monitoring an intraperitoneal pressure of the patient with the second pressure sensor; and transferring dialysate from the peritoneum of the patient to the drain container and monitoring the intraperitoneal pressure of the patient with the first pressure sensor.
In an embodiment, the step of transferring dialysate from the dialysate container to the peritoneum of the patient further comprises pumping dialysate from the dialysate container to the patient with a first pump disposed in-line between the dialysate container and the first pressure sensor.
In an embodiment, the step of transferring dialysate from the peritoneum of the patient to the drain container further comprises pumping dialysate from the peritoneum of the patient to the drain container with a second pump disposed in-line between the drain container and the second pressure sensor.
In an embodiment, the dialysate container is disposed vertically above the peritoneum of the patient and the step of transferring dialysate from the dialysate container to the peritoneum of the patient further comprises flowing dialysate from the dialysate container to the patient under a hydrostatic head.
In an embodiment, the drain container is disposed vertically below the peritoneum of the patient and the step of transferring dialysate from the peritoneum of the patient to the drain container further comprises flowing dialysate from the peritoneum of the patient to the drain container under a hydrostatic head.
Additional features and advantages are described herein, and will be apparent from the following Detailed Description and the figures.
It should be understood that the drawings are not necessarily to scale and that the embodiments are sometimes illustrated by graphic symbols, phantom lines, diagrammatic representations and fragmentary views. In certain instances, details which are not necessary for an understanding of the present invention or which render other details difficult to perceive may have been omitted. It should be understood, of course, that the invention is not necessarily limited to the particular embodiments illustrated herein.
Turning to
During the drain, the sensor 32 can accurately monitor and measure the intraperitoneal pressure of the patient 12. In the embodiment illustrated in
Turning to
Turning to
In the embodiment 70 illustrated in
When the left diaphragm pump 126 is pushing dialysate to the patient, the sensor 123 can measure the intraperitoneal pressure through the line 89. When the left diaphragm pump 126 is draining fluid from the patient through the line 89, the sensor 120 can measure intraperitoneal pressure through the line 88 and while the right pump 127 is pumping fluid to the drain container (not shown) through the drain line shown schematically at 128. When the right diaphragm pump 127 is being used to drain fluid from the patient, the sensor 120 can measure intraperitoneal pressure while the left diaphragm pump 126 is pumping fluid to the drain container (not shown) through the drain line shown schematically at 129.
A comparison of an APD therapy for a prior art APD cyclers and one manufactured in accordance with the present invention are summarized as follows:
Inspection of Table 1 shows that cycler 1 woke the patient at around 4:30 in the morning with a negative uF alarm at the beginning of Fill 5. The patient bypassed the alarm because he did not feel overrun and immediately fell back asleep. He woke up about 15 minutes later when he had difficulty breathing and felt extremely overfull. He manually drained about 1500 ml but was unable to go back to sleep. He filed a formal product complaint with the manufacturer.
The data of Table 1 shows that cycler 2 ran a completely normal therapy but the total therapy clearance (calculated based upon the sum of the night patient volumes) was only 84.5% of that obtained by cycler 3, which was using the cycler that used the method of the current invention.
The data of Table 1 shows that cycler 3 ran a completely normal therapy and that the fill volume was limited on one occasion by the maximum fill volume but on four occasions by the patient's intraperitoneal pressure. This patient never felt any discomfort and had no alarms during the night. The limit on the IPP prevented him from being overfilled even though he had successive drains that were not complete. The volume of fluid in his peritoneum never exceeded 3 liters.
The patient on cycler 1 had an intraperitoneal pressure in excess of 14 mm Hg during dwells 3 and 4. His breathing may have been impaired and his heart may have had to work harder but the discomfort was not enough to wake him up from a sound sleep until it peaked at 4,099 ml during dwell 5.
In conclusion, the method of the present invention provides for optimum fills and therefore more clearance while preventing overfills that bring discomfort and inhibit the function of vital body organs. A negative uF alarm would seldom occur because overfills of the required magnitude would be prevented by the IPP sensors.
In order to calculate the IPP, one may first calculate the patient head height correction using conservation of energy:
Δ(½pV2+P−ρagh)+Frictional Losses=0
The velocity V of fluid through the patient line is the same at both ends of the line as is the fluid density, so this equation can be written as
(P2−P1)−ρag(h2−h1)+Frictional Losses=0
which can be rearranged as
P1=1.25 psig=85060 (gram/cm)/(cm2-sec2)
P2=0.9 psig=61240 (gram/cm)/(cm2-sec2)
Frictional Losses=39130 (gram/cm)/(cm2-sec2) with flow of 197 cmn/min in a 4 mm ID line at a velocity of approximately 172 cm/sec, wherein
P1=1.25 psig=85060 (gram/cm)/(cm2-sec2)
P2=0.45 psig=30620 (gram/cm)/(cm2-sec2)
Frictional Losses=39130 (gram/cm)/(cm2-sec2) with flow of 197 cmn/min in a 4 mm ID line at a velocity of approximately 172 cm/sec, wherein
The patient head height can be established at the beginning of each fill. Any changes in the head height that occur during the fill can be attributed to an increase in intraperitoneal pressure (IPP) since the patient is asleep.
Turning to
It should be understood that various changes and modifications to the presently preferred embodiments described herein will be apparent to those skilled in the art. Such changes and modifications can be made without departing from the spirit and scope of the present subject matter and without diminishing its intended advantages. It is therefore intended that such changes and modifications be covered by the appended claims.
This application claims priority to and the benefit as a continuation of U.S. patent application Ser. No. 12/408,432, filed Mar. 20, 2009, which is a continuation of U.S. patent application Ser. No. 10/446,068, filed May 27, 2003, which is a divisional application of U.S. patent application Ser. No. 10/078,568, filed Feb. 14, 2002, issued as U.S. Pat. No. 6,592,542, which is a continuation of U.S. patent application Ser. No. 09/501,778, filed Feb. 10, 2000, issued as U.S. Pat. No. 6,497,676, the entire contents of each of which are incorporated herein by reference and relied upon.
Number | Name | Date | Kind |
---|---|---|---|
2286613 | Fuller | Jan 1942 | A |
3327115 | Barlett | Jan 1967 | A |
3485245 | Lahr et al. | Dec 1969 | A |
3620215 | Tysk et al. | Nov 1971 | A |
3626670 | Pecker | Dec 1971 | A |
3656873 | Schiff | Apr 1972 | A |
3689204 | Prisk | Sep 1972 | A |
3703959 | Raymond | Nov 1972 | A |
3707967 | Kitrilakis et al. | Jan 1973 | A |
3709222 | DeVries | Jan 1973 | A |
3792643 | Scheafer | Feb 1974 | A |
3902490 | Jacobsen | Sep 1975 | A |
3955901 | Hamilton | May 1976 | A |
3976574 | White | Aug 1976 | A |
3979284 | Granger | Sep 1976 | A |
4086653 | Gernes | Apr 1978 | A |
4126132 | Portner et al. | Nov 1978 | A |
4140118 | Jassawalla | Feb 1979 | A |
4142524 | Jassawalla et al. | Mar 1979 | A |
4158530 | Bernstein | Jun 1979 | A |
4181245 | Garrett et al. | Jan 1980 | A |
4187057 | Xanthopoulos | Feb 1980 | A |
4199307 | Jassawalla | Apr 1980 | A |
4235231 | Schindler et al. | Nov 1980 | A |
4236880 | Archibald | Dec 1980 | A |
4252651 | Soderstrom | Feb 1981 | A |
4265601 | Mandoian | May 1981 | A |
4273121 | Jassawalla | Jun 1981 | A |
4277226 | Archibald | Jul 1981 | A |
4303376 | Siekmann | Dec 1981 | A |
4310141 | Tamura | Jan 1982 | A |
4316466 | Babb | Feb 1982 | A |
4375346 | Kraus et al. | Mar 1983 | A |
4381003 | Buoncristiani | Apr 1983 | A |
4381005 | Bujan | Apr 1983 | A |
4382753 | Archibald | May 1983 | A |
4391600 | Archibald | Jul 1983 | A |
4410322 | Archibald | Oct 1983 | A |
4430048 | Fritsch | Feb 1984 | A |
4456218 | Kawabata et al. | Jun 1984 | A |
4468222 | Lundquist | Aug 1984 | A |
4479760 | Bilstad et al. | Oct 1984 | A |
4479761 | Bilstad et al. | Oct 1984 | A |
4479762 | Bilstad et al. | Oct 1984 | A |
4504038 | King | Mar 1985 | A |
4530759 | Schal | Jul 1985 | A |
4552552 | Polaschegg et al. | Nov 1985 | A |
4559036 | Wunsch | Dec 1985 | A |
4559044 | Robinson et al. | Dec 1985 | A |
4560472 | Granzow et al. | Dec 1985 | A |
4585436 | Davis et al. | Apr 1986 | A |
4613327 | Tegrarian et al. | Sep 1986 | A |
4618343 | Polaschegg | Oct 1986 | A |
RE32303 | Lasker et al. | Dec 1986 | E |
4634430 | Polaschegg | Jan 1987 | A |
4639245 | Pastrone et al. | Jan 1987 | A |
4642098 | Lundquist | Feb 1987 | A |
4648810 | Schippers et al. | Mar 1987 | A |
4648872 | Kamen | Mar 1987 | A |
4657490 | Abbott | Apr 1987 | A |
4694848 | Jorgensen et al. | Sep 1987 | A |
4703773 | Hansen et al. | Nov 1987 | A |
4717117 | Cook | Jan 1988 | A |
4718890 | Peabody | Jan 1988 | A |
4747822 | Peabody | May 1988 | A |
4769134 | Allan et al. | Sep 1988 | A |
4778356 | Hicks | Oct 1988 | A |
4778451 | Kamen | Oct 1988 | A |
4784576 | Bloom et al. | Nov 1988 | A |
4808161 | Kamen | Feb 1989 | A |
4816019 | Kamen | Mar 1989 | A |
4818186 | Pastrone et al. | Apr 1989 | A |
4818190 | Pelmulder et al. | Apr 1989 | A |
4823552 | Ezell et al. | Apr 1989 | A |
4826482 | Kamen | May 1989 | A |
4828545 | Epstein et al. | May 1989 | A |
4830586 | Herter et al. | May 1989 | A |
4842582 | Mahurkar | Jun 1989 | A |
4842584 | Pastrone | Jun 1989 | A |
4848722 | Webster | Jul 1989 | A |
4850805 | Madsen et al. | Jul 1989 | A |
4852851 | Webster | Aug 1989 | A |
4855356 | Holub et al. | Aug 1989 | A |
4859319 | Borsari | Aug 1989 | A |
4865584 | Epstein et al. | Sep 1989 | A |
4872813 | Gorton et al. | Oct 1989 | A |
4886432 | Kimberlin | Dec 1989 | A |
4927411 | Pastrone et al. | May 1990 | A |
4942735 | Mushika et al. | Jul 1990 | A |
5002471 | Perlov | Mar 1991 | A |
5006050 | Cooke et al. | Apr 1991 | A |
5062774 | Kramer et al. | Nov 1991 | A |
5088515 | Kamen | Feb 1992 | A |
5094820 | Maxwell et al. | Mar 1992 | A |
5098262 | Wrecker et al. | Mar 1992 | A |
5108844 | Blumberg et al. | Apr 1992 | A |
5125891 | Hossain et al. | Jun 1992 | A |
5141493 | Jacobsen et al. | Aug 1992 | A |
5163900 | Wortrich | Nov 1992 | A |
5176956 | Jevne et al. | Jan 1993 | A |
5178182 | Kamen | Jan 1993 | A |
5185084 | Lapidus et al. | Feb 1993 | A |
5195960 | Hossain et al. | Mar 1993 | A |
5207642 | Orkin et al. | May 1993 | A |
5241985 | Faust et al. | Sep 1993 | A |
5245693 | Ford et al. | Sep 1993 | A |
5247434 | Peterson et al. | Sep 1993 | A |
5252044 | Raines et al. | Oct 1993 | A |
5292306 | Wynkoop et al. | Mar 1994 | A |
5302093 | Owens et al. | Apr 1994 | A |
5316452 | Bogen et al. | May 1994 | A |
5332372 | Reynolds | Jul 1994 | A |
5344292 | Rabenau et al. | Sep 1994 | A |
5350357 | Kamen et al. | Sep 1994 | A |
5378126 | Abrahamson et al. | Jan 1995 | A |
5389243 | Kaplan | Feb 1995 | A |
5397222 | Moss et al. | Mar 1995 | A |
5409355 | Brooke | Apr 1995 | A |
5415528 | Ogden et al. | May 1995 | A |
5421208 | Packard et al. | Jun 1995 | A |
5421823 | Kamen et al. | Jun 1995 | A |
5429485 | Dodge | Jul 1995 | A |
5431626 | Bryant et al. | Jul 1995 | A |
5458468 | Ye et al. | Oct 1995 | A |
5474683 | Bryant et al. | Dec 1995 | A |
5476368 | Rabenau et al. | Dec 1995 | A |
5482440 | Dennehey et al. | Jan 1996 | A |
5487649 | Dorsey, III et al. | Jan 1996 | A |
5522769 | DeGuiseppi | Jun 1996 | A |
5526844 | Kamen | Jun 1996 | A |
5533389 | Kamen et al. | Jul 1996 | A |
5536412 | Ash | Jul 1996 | A |
5542919 | Simon et al. | Aug 1996 | A |
5554013 | Owens et al. | Sep 1996 | A |
5556263 | Jacobsen et al. | Sep 1996 | A |
5570716 | Kamen et al. | Nov 1996 | A |
5575310 | Kamen et al. | Nov 1996 | A |
5578012 | Kamen et al. | Nov 1996 | A |
5580460 | Polaschegg | Dec 1996 | A |
5586868 | Lawless et al. | Dec 1996 | A |
5588816 | Abbott et al. | Dec 1996 | A |
5591344 | Kenley et al. | Jan 1997 | A |
5603354 | Jacobsen et al. | Feb 1997 | A |
5609572 | Lang | Mar 1997 | A |
5620312 | Hyman et al. | Apr 1997 | A |
5628908 | Kamen et al. | May 1997 | A |
5630935 | Treu | May 1997 | A |
5632606 | Jacobsen et al. | May 1997 | A |
5634896 | Bryant et al. | Jun 1997 | A |
5645734 | Kenley et al. | Jul 1997 | A |
5669764 | Behringer et al. | Sep 1997 | A |
5718692 | Schon et al. | Feb 1998 | A |
5722947 | Jeppsson et al. | Mar 1998 | A |
5758563 | Robinson | Jun 1998 | A |
5788671 | Johnson | Aug 1998 | A |
5790752 | Anglin et al. | Aug 1998 | A |
5807075 | Jacobsen et al. | Sep 1998 | A |
5814004 | Tamari | Sep 1998 | A |
5816779 | Lawless et al. | Oct 1998 | A |
5836908 | Beden et al. | Nov 1998 | A |
5871566 | Rutz | Feb 1999 | A |
5919369 | Ash | Jul 1999 | A |
5921951 | Morris | Jul 1999 | A |
5924975 | Goldowsky | Jul 1999 | A |
5931647 | Jacobsen et al. | Aug 1999 | A |
5938634 | Packard | Aug 1999 | A |
5944495 | Jacobsen et al. | Aug 1999 | A |
5944684 | Roberts et al. | Aug 1999 | A |
5965433 | Gardetto et al. | Oct 1999 | A |
5989423 | Kamen et al. | Nov 1999 | A |
6007310 | Jacobsen et al. | Dec 1999 | A |
6017194 | North, Jr. | Jan 2000 | A |
6030359 | Nowosielski | Feb 2000 | A |
6036668 | Mathis | Mar 2000 | A |
6041801 | Gray et al. | Mar 2000 | A |
6065941 | Gray et al. | May 2000 | A |
6126403 | Yamada | Oct 2000 | A |
6129699 | Haight et al. | Oct 2000 | A |
6165154 | Gray et al. | Dec 2000 | A |
6208107 | Maske et al. | Mar 2001 | B1 |
6210361 | Kamen et al. | Apr 2001 | B1 |
6223130 | Gray et al. | Apr 2001 | B1 |
6228047 | Dadson | May 2001 | B1 |
6231320 | Lawless et al. | May 2001 | B1 |
6234991 | Gorsuch | May 2001 | B1 |
6234997 | Kamen et al. | May 2001 | B1 |
6245039 | Brugger et al. | Jun 2001 | B1 |
6248093 | Moberg | Jun 2001 | B1 |
6254567 | Treu et al. | Jul 2001 | B1 |
6270673 | Belt et al. | Aug 2001 | B1 |
6280408 | Sipin | Aug 2001 | B1 |
6302653 | Bryant et al. | Oct 2001 | B1 |
6343614 | Gray et al. | Feb 2002 | B1 |
6364857 | Gray et al. | Apr 2002 | B1 |
6382923 | Gray | May 2002 | B1 |
6416293 | Bouchard et al. | Jul 2002 | B1 |
6491656 | Morris | Dec 2002 | B1 |
6491658 | Miura et al. | Dec 2002 | B1 |
6497676 | Childers et al. | Dec 2002 | B1 |
6595948 | Suzuki et al. | Jul 2003 | B2 |
6743201 | Dönig et al. | Jun 2004 | B1 |
6814547 | Childers et al. | Nov 2004 | B2 |
6949079 | Westberg et al. | Sep 2005 | B1 |
7004924 | Brugger et al. | Feb 2006 | B1 |
20010018937 | Nemoto | Sep 2001 | A1 |
20020045851 | Suzuki et al. | Apr 2002 | A1 |
Number | Date | Country |
---|---|---|
0 028 371 | May 1981 | EP |
0 033 096 | Aug 1981 | EP |
0 052 004 | May 1982 | EP |
0 097 432 | Jan 1984 | EP |
0 157 024 | Oct 1985 | EP |
0 206 195 | Dec 1986 | EP |
0 319 272 | Jun 1989 | EP |
0 402 505 | Dec 1990 | EP |
0 660 725 | Jul 1995 | EP |
1 326 236 | Aug 1973 | GB |
8504813 | Nov 1985 | WO |
8601115 | Feb 1986 | WO |
8705223 | Sep 1987 | WO |
8901795 | Mar 1989 | WO |
9013795 | Nov 1990 | WO |
9420158 | Sep 1994 | WO |
03099355 | Dec 2003 | WO |
Number | Date | Country | |
---|---|---|---|
20110028892 A1 | Feb 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10078568 | Feb 2002 | US |
Child | 10446068 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12408432 | Mar 2009 | US |
Child | 12903820 | US | |
Parent | 10446068 | May 2003 | US |
Child | 12408432 | US | |
Parent | 09501778 | Feb 2000 | US |
Child | 10078568 | US |